chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone normal, Blood triglycerides, Blood urea normal, Brain natriuretic peptide increased, Carbon dioxide normal
Clinical narrative: Patient is a 22 y.o. male with PMH of obesity who presented to ED on 5/22 with c/o chest pain 3 days after receiving his second dose of Pfizer COVID-19 vaccine. Trop elevated to 12.7 and ECG with diffuse ST segment elevation consistent with pericarditis. He had an episode of NSVT. Trop peak 29. Patient was started on ASA + colchicine and metoprolol. TTE revealed LVEF 49% with multiple segmental abnormalities. Due to concern for worsening arrhythmia and possible need for myocardial biopsy patient was transferred to BMMC on 5/23.    Cardiology was consulted and cardiac MRI was performed. No further arrhythmias noted on telemetry monitoring. Cardiac MRI revealed LVEF 57% RVEF 53%, no vasodilator induced perfusion defect, delayed enhancement MRI is abnormal, epicardial enhancement of distal anterior and anterolateral walls with small pericardial effusion, consistent with perimyocarditis. Patient chest pain resolved and he denied other associated symptoms.Ttroponin level down to 5, VSS. Medically stable for discharge with no strenuous activities until inflammatory biomarkers normalize and close f/u with cardiology in 1 week.    New medications: - ASA 650mg TID for 7 days followed by ASA 325mg daily - Colchicine 0.6mg BID for at least 3 months - Metoprolol succinate 25mg daily    Follow up with cardiology clinic in 1 week with CRP, ESR, and troponin
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac imaging procedure abnormal, Chest pain, Echocardiogram, Ejection fraction decreased, Electrocardiogram ST segment elevation
Clinical narrative: Patient is a 22 y.o. male with PMH of obesity who presented to ED on 5/22 with c/o chest pain 3 days after receiving his second dose of Pfizer COVID-19 vaccine. Trop elevated to 12.7 and ECG with diffuse ST segment elevation consistent with pericarditis. He had an episode of NSVT. Trop peak 29. Patient was started on ASA + colchicine and metoprolol. TTE revealed LVEF 49% with multiple segmental abnormalities. Due to concern for worsening arrhythmia and possible need for myocardial biopsy patient was transferred to BMMC on 5/23.    Cardiology was consulted and cardiac MRI was performed. No further arrhythmias noted on telemetry monitoring. Cardiac MRI revealed LVEF 57% RVEF 53%, no vasodilator induced perfusion defect, delayed enhancement MRI is abnormal, epicardial enhancement of distal anterior and anterolateral walls with small pericardial effusion, consistent with perimyocarditis. Patient chest pain resolved and he denied other associated symptoms.Ttroponin level down to 5, VSS. Medically stable for discharge with no strenuous activities until inflammatory biomarkers normalize and close f/u with cardiology in 1 week.    New medications: - ASA 650mg TID for 7 days followed by ASA 325mg daily - Colchicine 0.6mg BID for at least 3 months - Metoprolol succinate 25mg daily    Follow up with cardiology clinic in 1 week with CRP, ESR, and troponin
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Haematocrit decreased, Haemoglobin decreased, International normalised ratio increased, LDL/HDL ratio
Clinical narrative: Patient is a 22 y.o. male with PMH of obesity who presented to ED on 5/22 with c/o chest pain 3 days after receiving his second dose of Pfizer COVID-19 vaccine. Trop elevated to 12.7 and ECG with diffuse ST segment elevation consistent with pericarditis. He had an episode of NSVT. Trop peak 29. Patient was started on ASA + colchicine and metoprolol. TTE revealed LVEF 49% with multiple segmental abnormalities. Due to concern for worsening arrhythmia and possible need for myocardial biopsy patient was transferred to BMMC on 5/23.    Cardiology was consulted and cardiac MRI was performed. No further arrhythmias noted on telemetry monitoring. Cardiac MRI revealed LVEF 57% RVEF 53%, no vasodilator induced perfusion defect, delayed enhancement MRI is abnormal, epicardial enhancement of distal anterior and anterolateral walls with small pericardial effusion, consistent with perimyocarditis. Patient chest pain resolved and he denied other associated symptoms.Ttroponin level down to 5, VSS. Medically stable for discharge with no strenuous activities until inflammatory biomarkers normalize and close f/u with cardiology in 1 week.    New medications: - ASA 650mg TID for 7 days followed by ASA 325mg daily - Colchicine 0.6mg BID for at least 3 months - Metoprolol succinate 25mg daily    Follow up with cardiology clinic in 1 week with CRP, ESR, and troponin
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test, Low density lipoprotein, Lymphocyte percentage decreased, Magnetic resonance imaging heart, Mean cell volume normal
Clinical narrative: Patient is a 22 y.o. male with PMH of obesity who presented to ED on 5/22 with c/o chest pain 3 days after receiving his second dose of Pfizer COVID-19 vaccine. Trop elevated to 12.7 and ECG with diffuse ST segment elevation consistent with pericarditis. He had an episode of NSVT. Trop peak 29. Patient was started on ASA + colchicine and metoprolol. TTE revealed LVEF 49% with multiple segmental abnormalities. Due to concern for worsening arrhythmia and possible need for myocardial biopsy patient was transferred to BMMC on 5/23.    Cardiology was consulted and cardiac MRI was performed. No further arrhythmias noted on telemetry monitoring. Cardiac MRI revealed LVEF 57% RVEF 53%, no vasodilator induced perfusion defect, delayed enhancement MRI is abnormal, epicardial enhancement of distal anterior and anterolateral walls with small pericardial effusion, consistent with perimyocarditis. Patient chest pain resolved and he denied other associated symptoms.Ttroponin level down to 5, VSS. Medically stable for discharge with no strenuous activities until inflammatory biomarkers normalize and close f/u with cardiology in 1 week.    New medications: - ASA 650mg TID for 7 days followed by ASA 325mg daily - Colchicine 0.6mg BID for at least 3 months - Metoprolol succinate 25mg daily    Follow up with cardiology clinic in 1 week with CRP, ESR, and troponin
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Myocarditis, Non-high-density lipoprotein cholesterol, Pericardial effusion, Pericarditis, Platelet count normal
Clinical narrative: Patient is a 22 y.o. male with PMH of obesity who presented to ED on 5/22 with c/o chest pain 3 days after receiving his second dose of Pfizer COVID-19 vaccine. Trop elevated to 12.7 and ECG with diffuse ST segment elevation consistent with pericarditis. He had an episode of NSVT. Trop peak 29. Patient was started on ASA + colchicine and metoprolol. TTE revealed LVEF 49% with multiple segmental abnormalities. Due to concern for worsening arrhythmia and possible need for myocardial biopsy patient was transferred to BMMC on 5/23.    Cardiology was consulted and cardiac MRI was performed. No further arrhythmias noted on telemetry monitoring. Cardiac MRI revealed LVEF 57% RVEF 53%, no vasodilator induced perfusion defect, delayed enhancement MRI is abnormal, epicardial enhancement of distal anterior and anterolateral walls with small pericardial effusion, consistent with perimyocarditis. Patient chest pain resolved and he denied other associated symptoms.Ttroponin level down to 5, VSS. Medically stable for discharge with no strenuous activities until inflammatory biomarkers normalize and close f/u with cardiology in 1 week.    New medications: - ASA 650mg TID for 7 days followed by ASA 325mg daily - Colchicine 0.6mg BID for at least 3 months - Metoprolol succinate 25mg daily    Follow up with cardiology clinic in 1 week with CRP, ESR, and troponin
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Protein total normal, Red blood cell count normal, Troponin I increased, Troponin increased, Ventricular tachycardia
Clinical narrative: Patient is a 22 y.o. male with PMH of obesity who presented to ED on 5/22 with c/o chest pain 3 days after receiving his second dose of Pfizer COVID-19 vaccine. Trop elevated to 12.7 and ECG with diffuse ST segment elevation consistent with pericarditis. He had an episode of NSVT. Trop peak 29. Patient was started on ASA + colchicine and metoprolol. TTE revealed LVEF 49% with multiple segmental abnormalities. Due to concern for worsening arrhythmia and possible need for myocardial biopsy patient was transferred to BMMC on 5/23.    Cardiology was consulted and cardiac MRI was performed. No further arrhythmias noted on telemetry monitoring. Cardiac MRI revealed LVEF 57% RVEF 53%, no vasodilator induced perfusion defect, delayed enhancement MRI is abnormal, epicardial enhancement of distal anterior and anterolateral walls with small pericardial effusion, consistent with perimyocarditis. Patient chest pain resolved and he denied other associated symptoms.Ttroponin level down to 5, VSS. Medically stable for discharge with no strenuous activities until inflammatory biomarkers normalize and close f/u with cardiology in 1 week.    New medications: - ASA 650mg TID for 7 days followed by ASA 325mg daily - Colchicine 0.6mg BID for at least 3 months - Metoprolol succinate 25mg daily    Follow up with cardiology clinic in 1 week with CRP, ESR, and troponin
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Patient is a 22 y.o. male with PMH of obesity who presented to ED on 5/22 with c/o chest pain 3 days after receiving his second dose of Pfizer COVID-19 vaccine. Trop elevated to 12.7 and ECG with diffuse ST segment elevation consistent with pericarditis. He had an episode of NSVT. Trop peak 29. Patient was started on ASA + colchicine and metoprolol. TTE revealed LVEF 49% with multiple segmental abnormalities. Due to concern for worsening arrhythmia and possible need for myocardial biopsy patient was transferred to BMMC on 5/23.    Cardiology was consulted and cardiac MRI was performed. No further arrhythmias noted on telemetry monitoring. Cardiac MRI revealed LVEF 57% RVEF 53%, no vasodilator induced perfusion defect, delayed enhancement MRI is abnormal, epicardial enhancement of distal anterior and anterolateral walls with small pericardial effusion, consistent with perimyocarditis. Patient chest pain resolved and he denied other associated symptoms.Ttroponin level down to 5, VSS. Medically stable for discharge with no strenuous activities until inflammatory biomarkers normalize and close f/u with cardiology in 1 week.    New medications: - ASA 650mg TID for 7 days followed by ASA 325mg daily - Colchicine 0.6mg BID for at least 3 months - Metoprolol succinate 25mg daily    Follow up with cardiology clinic in 1 week with CRP, ESR, and troponin
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Paraesthesia oral, Throat tightness
Clinical narrative: Patient complained of facial flushing, tingling lips, and his throat feeling like it was tightening.  Nurse administered 25mg IM Benadryl per clinic protocol. The reaction resolved after administration of IM Benadryl.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dry throat, Throat tightness
Clinical narrative: I feel throat tightness, dry throat since vaccinated. i hope this is not serious. Sorry if i should not report this.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis, Septic shock
Clinical narrative: Patient presented to the ED and was subsequently hospitalized within 6 weeks of receiving COVID vaccination. Diagnosis was severe sepsis with septic shock.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Myalgia
Clinical narrative: Soreness, Fatigue, Headache, Sweats, Muscle Aches, Chills -- symptoms subsided within 24-48 hrs.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Soreness, Fatigue, Headache, Sweats, Muscle Aches, Chills -- symptoms subsided within 24-48 hrs.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Cough, Eye disorder, Neurological symptom
Clinical narrative: bells palsey - severe issue in left eye and left side; minor chest cough I didn't have before
Age: 15.0
Sex: F
Vaccine: UNK
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: My daughter was given the wrong Vaccine. She received the moderana not the Pitzer.  The first shot  Not sure what to do????Please advise. She has no side effects so far.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Peripheral swelling, Skin warm
Clinical narrative: I felt fatigue and my arm was immediately swollen hard and hot to the touch. My arm was back to normal after a week.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Small rash that started on my chest, then spread all over my chest, arms, neck, head, back and stomach.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Chest discomfort, Dizziness, Full blood count, Laboratory test normal
Clinical narrative: Pt and pt's daughter were in triage area, post-vaccination (1st dose PFIZER), c/o dizziness and non-radiating chest pressure located in midsection of chest, at approximately 7:50PM. On-site NP and clinic lead notified. Pt denied experiencing SOB or any other new/abnormal sx. Pt denied hx of smoking or taking BP meds. Pt was offered and given water.   V/S @ 750PM: BP - 150/102, HR - 86, O2 - 98% V/S @ 758PM: BP - 167/106, HR - 90, O2 - 99% V/S @ 800PM: BP - 160/102, HR - 90, O2% - 99%   Continued to monitor pt. Pt denied experiencing improvement to sxs.    V/S @ 810PM: BP - 155/95, HR - 97   Pt denied experiencing any improvement to sxs. ED precautions given. Pt was encouraged to see ED. Pt agreed and requested to be transferred to ED via w/c. Pt was accompanied by NP, RN, and pt's daughter to ED. Report given to ED nurse.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin normal
Clinical narrative: Pt and pt's daughter were in triage area, post-vaccination (1st dose PFIZER), c/o dizziness and non-radiating chest pressure located in midsection of chest, at approximately 7:50PM. On-site NP and clinic lead notified. Pt denied experiencing SOB or any other new/abnormal sx. Pt denied hx of smoking or taking BP meds. Pt was offered and given water.   V/S @ 750PM: BP - 150/102, HR - 86, O2 - 98% V/S @ 758PM: BP - 167/106, HR - 90, O2 - 99% V/S @ 800PM: BP - 160/102, HR - 90, O2% - 99%   Continued to monitor pt. Pt denied experiencing improvement to sxs.    V/S @ 810PM: BP - 155/95, HR - 97   Pt denied experiencing any improvement to sxs. ED precautions given. Pt was encouraged to see ED. Pt agreed and requested to be transferred to ED via w/c. Pt was accompanied by NP, RN, and pt's daughter to ED. Report given to ED nurse.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine was administered outside of storage recommendations. Notified pt to return for re-vaccination
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Exposure during pregnancy, Haemorrhage, Ultrasound scan
Clinical narrative: Beginning on day of dose one, tired, achy I had redness. Second dose was end of May. I was pregnant at the time. I started having a lot of bleeding and I went to ER.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling
Clinical narrative: bilateral ankle swelling, Left more than right
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Myocarditis, Troponin increased
Clinical narrative: Patient with no past medical history here with acute myopericarditis post 2nd dose of Pfizer COVID-19 vaccine.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Depression, Feeling of despair, Malaise
Clinical narrative: Two weeks after second dose of Moderna he woke up very ill.  Fever, nausea, no appetite, weakness, aching, and has since lost 35 lbs, continues to be very weak, no appetite and is very depressed and is about to give up hope and feels like he is dying.  Encouraged him to see dr. sooner than his scheduled June 25 visit and lab work.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Weight decreased
Clinical narrative: Two weeks after second dose of Moderna he woke up very ill.  Fever, nausea, no appetite, weakness, aching, and has since lost 35 lbs, continues to be very weak, no appetite and is very depressed and is about to give up hope and feels like he is dying.  Encouraged him to see dr. sooner than his scheduled June 25 visit and lab work.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dry throat, Dyspnoea, Head discomfort, Headache, Tracheal inflammation
Clinical narrative: Esporádic  severe headache pressure pain, treatment: Tylenol Traquea swollen and dry, unable to breath only while sleeping  head up. Treatment: drink some water and sleep on the side
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Laboratory test normal, Magnetic resonance imaging, Muscle spasms, Muscle twitching
Clinical narrative: 7pm night of shot and has not gone away Muscle spasms and twitching Elevated heart rate
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Condition aggravated, Feeling abnormal, Nausea, Pyrexia
Clinical narrative: **Please note, the report does not mention which COVID vaccine, only that it was the second vaccine so we are not certain if it was Pfizer or Moderna)   The patient presents 6/5/21  with fever, Began feeling poorly the night prior. Received second COVID vaccine 6/4/21. Mild abdominal pain worsening throughout night. Fever noticed this morning. Mild nausea without vomiting or diarrhea. Denies ill contacts. S/P red cell exchange 6/2/2011 and no chest pain. The fever began last night, the maximum temperature is subjective and course is constant. The associated symptom is none. Differential Diagnosis: Fever, viral syndrome, Vaccine reaction. Heme recommends Reviewed case and labs. Recommends single dose Rocephin IV and agrees PT is stable for discharge home pending F/U in clinic. Pt sleeping. Sao2 88% on room air. PT feels the same. Plan to admit for obs.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication, Viral infection
Clinical narrative: **Please note, the report does not mention which COVID vaccine, only that it was the second vaccine so we are not certain if it was Pfizer or Moderna)   The patient presents 6/5/21  with fever, Began feeling poorly the night prior. Received second COVID vaccine 6/4/21. Mild abdominal pain worsening throughout night. Fever noticed this morning. Mild nausea without vomiting or diarrhea. Denies ill contacts. S/P red cell exchange 6/2/2011 and no chest pain. The fever began last night, the maximum temperature is subjective and course is constant. The associated symptom is none. Differential Diagnosis: Fever, viral syndrome, Vaccine reaction. Heme recommends Reviewed case and labs. Recommends single dose Rocephin IV and agrees PT is stable for discharge home pending F/U in clinic. Pt sleeping. Sao2 88% on room air. PT feels the same. Plan to admit for obs.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Bone swelling, Fatigue, Hypoaesthesia, Muscle twitching, Pain
Clinical narrative: Twitching of upper left arm Twitching of left abdominal side Fever and swelling of clavicle bone on left side, protruding, tender and with fever Passing face numbing others maybe more expected: fatigue/soreness for about 1-2 days after the shot was given.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Physical examination normal, Pyrexia
Clinical narrative: Twitching of upper left arm Twitching of left abdominal side Fever and swelling of clavicle bone on left side, protruding, tender and with fever Passing face numbing others maybe more expected: fatigue/soreness for about 1-2 days after the shot was given.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Headache, Magnetic resonance imaging head abnormal, Superior sagittal sinus thrombosis
Clinical narrative: He received the first dose of pzifer on 5/14/21. 3-4 days later he developed a headache and was found to have superior sagittal sinus thrombosis. He was started on Pradaxa but later returned with worsening headache and repeat MRV head showing more extensive sagittal sinus thrombosis. He is now being treated with lovenox.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Pain and swelling at the injection location.  Extreme tiredness, headache, muscle pain/soreness, chills and intermittent  (minimal) nausea.  Felt like my body was working harder than normal, with slight tightness in my chest.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site swelling, Myalgia, Nausea
Clinical narrative: Pain and swelling at the injection location.  Extreme tiredness, headache, muscle pain/soreness, chills and intermittent  (minimal) nausea.  Felt like my body was working harder than normal, with slight tightness in my chest.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Immunisation, Product storage error
Clinical narrative: vaccine was administered outside of storage recommendations. Notified pt to return for re-vaccination
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Dizziness, Electrocardiogram normal
Clinical narrative: I had a mild dizziness that started on the 20th of May and has been ongoing ever since (stops and starts). I saw my Dr. the week after that and she ordered tests.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush
Clinical narrative: Received 2nd Covid 19 vaccine today.  10 minutes later, complained of hot flashes up and down body.  No other symptoms.   Symptoms did not worsen or get better.   Stayed the same.  Advised to go to urgent care.  Patient declined at this time.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstruation delayed
Clinical narrative: Periods were very regular prior to vaccination with my last period being 04/01/2021.  I have not had a period since receiving the vaccination.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Arthralgia, Back pain, Dizziness, Feeling hot
Clinical narrative: Patient was feeling "hot"  immediately after vaccination.  Sitting in waiting area/  Put head down on knees.  Feels room is "too close".  Pulse and BP normal.  Reports anxiety in past.  Encouraged slow deep breathing.  Relaxes after conversing about normal symptoms.  Gave literature on symptoms, v-safe.  Encouraged V-safe enrollment.  Gave bottled water.  Encouraged plenty of fluids and rest today.   C/o "tightness" in shoulders and back.  Encouraged relaxation and rest.  Symptoms present:  Lightheadedness. Anxiety.  Orientation x 3, Back and shoulders were achy.  "Hot" right after shot, then resolved.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: PFIZER VACCINE WAS PLACED IN FREEZER 05062021 AND DUE TO BE MOVED TO REFRIGERATOR 05192021.  VACCINE WAS LEFT IN FREEZER UNTIL 05212021 THEN MOVED TO REFRIGERATOR.  IMMUNIZATION PROGRAM WAS NOTIFIED OF ISSUE ON 05252021 AND SENT EMAIL STATING  VACCINE AS SAFE TO USE .  05272021 IP EMAILED  VACCINE WAS NOT SAFE TO USE AND TO DESTROY THE VACCINE.  THEN IP EMAILED 05282021 THAT PFIZER PHARMACIST HAD DEEMED VACCINE STABLE AND IT WAS SAFE TO USE SO DOSES GIVEN 05252021 WERE GOOD.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Client states that after her 1st dose Pfizer COVID vaccine (LOT: EW0179, Expiration 08/31/2021) received 05/06/2021 she developed a bilateral inner arm and belly rash during her 15 minute observation period. She reported she did not alert the EMTs at the time but left the site and went home to take a 25mg Benadryl. She stated the symptoms resolved approximately 1.5 hours after taking the Benadryl and did not return She denied any other symptoms such as chest pain, shortness of breath, facial swelling, tongue, mouth, throat swelling or tingling. She reported positive for an anaphylactic reaction to strawberries, but otherwise denied allergies to any other medications/foods/environment. She denied any other significant medical history or medication use.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Hypoxia, Pain, Swelling face
Clinical narrative: Facial swelling, Mild hypoxia, body aches. Anaphylaxis
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatine phosphokinase increased, Blood lactic acid increased, Dyspnoea, Myalgia, Pyrexia
Clinical narrative: Facial swelling, Mild hypoxia, body aches. Anaphylaxis
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Swelling face
Clinical narrative: Facial swelling, Mild hypoxia, body aches. Anaphylaxis
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Hypoxia, Pain, Swelling face
Clinical narrative: facial swelling, muscle aches, shortness of breath, fever
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatine phosphokinase increased, Blood lactic acid increased, Dyspnoea, Myalgia, Pyrexia
Clinical narrative: facial swelling, muscle aches, shortness of breath, fever
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Swelling face
Clinical narrative: facial swelling, muscle aches, shortness of breath, fever
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: 1. Acute deep vein thrombosis (DVT) of tibial vein of left lower extremity (CMS/HCC)   No history of any DVT
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Loss of consciousness, Nausea
Clinical narrative: Patient received his second dose Moderna and sat in our waiting area.  He got up to tell us he was feeling nauseous and dizzy and he passed out.  We lifted his head and legs and called EMS.  EMS came and patient was ok.  He passed out again when they checked his blood sugar but was seated and did not fall.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Pt was reported to be "anxious and nervous" about receiving her first dose of Moderna vaccine "all day" by her husband.  Pt c/o feeling nauseous 10 minutes after receiving vaccine and vomiting once in restroom after completing the required 15 minute observation period at vaccine site.  Pt walked back into POD to be evaluated by writer (clinical lead), pt reported a headache after vomiting, denied any blood in her vomit.   Denied any dizziness, chest pain, fever, chills, difficulty breathing, rashes, itching, difficulty speaking or swallowing, abdominal pain, weakness, numbness, tingling, or diarrhea.  Pt was given water and evaluated by writer (clinical lead at site, and co-leads) and observed for and additional 30 minutes while obtaining history.  Pt tolerated water PO and did not vomit in the presence of writer.  Vital signs were stable and pt reported feeling "better".  Physical exam was unremarkable: lungs clear, no increased work of breathing or accessory muscle use noted, airway patent, no facial, lip, or tongue swelling noted, no rashes observed, and abdomen soft and non-tender. Pt was discharged home from vaccine POD after evaluation completed.  No additional vomiting or new symptoms were reported by pt or husband while still on the vaccine POD premises.  Instructions provided to pt were to remain hydrated with clear liquids, advance to BRAT diet as tolerated, and pt instructed to go to ER if any new symptoms arise or anything worsens.  Pt and family member emphasized understanding, and all questions were answered.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Injection site pain, Myalgia, Nausea
Clinical narrative: HA, muscle aches, dizziness, soreness at injection site, mild nausea
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Vaccine positive rechallenge
Clinical narrative: This is the reaction to the second dose of Covid-19 Moderna. Just like with the first dose I got the 'Covid Arm'. The rash was longer, all along the biceps brachi.  The 'Covid arm' didn't  itch.  But I got again itching rashes in the upper body: head, face and neck. These latter where less prominent and the itching milder than the first dose. As with the first dose I applied to the arm rash Hydrocortisone cream USP 2.5%. Stopped using the cream after the 8th day since the rash is fading away.  It's been 12 days since I got this second dose and so far have no other reaction.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site irritation, Pain in extremity
Clinical narrative: Redness, irritation near site of injection beginning 10 days after injection was administered. Pt also mentioned continued soreness in the arm 28 days after administration
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Acoustic stimulation tests normal, Allergy test positive, Delirium, Disorientation, Headache
Clinical narrative: april 3 hyperacusis april 8 hyperacusis amplified to inability to work and tinnitus started.   disorientation feelings.  no sleep possible. no sound masking possible. tinnitus was louder than two sound machines on FULL volume.  april 13. GP prescribes claritin, flonase (double dose), neomycin drops april 18 brain on fire with headache, pain april 19 ENT did blood work, visual and hearing tests. stopped flonase. started azelastine.  april 26. started to hear crackling in right ear april 27 soreness below right ear  may 2 SETBACK almost a panic attack (I assume) hyperacusis returned but not as severe as before.  may 3 new ENT restarted flonase (double dose) may 6 brain on fire again. reduced flonase to normal dose.  may 10 rock hard lymph node right side below ear. feeling better on lower flonase.   may 11 lesser panic attack. lesser hyperacusis reaction.  may 13 given doxycyclene 7 days june 3 slept without sound machine 8 weeks in
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperacusis, Impaired work ability, Induration, Pain, Panic attack
Clinical narrative: april 3 hyperacusis april 8 hyperacusis amplified to inability to work and tinnitus started.   disorientation feelings.  no sleep possible. no sound masking possible. tinnitus was louder than two sound machines on FULL volume.  april 13. GP prescribes claritin, flonase (double dose), neomycin drops april 18 brain on fire with headache, pain april 19 ENT did blood work, visual and hearing tests. stopped flonase. started azelastine.  april 26. started to hear crackling in right ear april 27 soreness below right ear  may 2 SETBACK almost a panic attack (I assume) hyperacusis returned but not as severe as before.  may 3 new ENT restarted flonase (double dose) may 6 brain on fire again. reduced flonase to normal dose.  may 10 rock hard lymph node right side below ear. feeling better on lower flonase.   may 11 lesser panic attack. lesser hyperacusis reaction.  may 13 given doxycyclene 7 days june 3 slept without sound machine 8 weeks in
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep disorder, Tinnitus
Clinical narrative: april 3 hyperacusis april 8 hyperacusis amplified to inability to work and tinnitus started.   disorientation feelings.  no sleep possible. no sound masking possible. tinnitus was louder than two sound machines on FULL volume.  april 13. GP prescribes claritin, flonase (double dose), neomycin drops april 18 brain on fire with headache, pain april 19 ENT did blood work, visual and hearing tests. stopped flonase. started azelastine.  april 26. started to hear crackling in right ear april 27 soreness below right ear  may 2 SETBACK almost a panic attack (I assume) hyperacusis returned but not as severe as before.  may 3 new ENT restarted flonase (double dose) may 6 brain on fire again. reduced flonase to normal dose.  may 10 rock hard lymph node right side below ear. feeling better on lower flonase.   may 11 lesser panic attack. lesser hyperacusis reaction.  may 13 given doxycyclene 7 days june 3 slept without sound machine 8 weeks in
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Headache
Clinical narrative: Pt got Moderna COVIDvaccine on 6/4/21 in the evening  and said she had some headache on 6/5/21 we told her to take Tylenol and let us know if it helped or got worse. She called back today 6/7/21  stating that the Tylenol worked for the headache. However, her husband mentioned to her that over the previous 24 hours, she had episodes of confusion where she didn't understand what he was saying. We gave her VAERS phone number so she could report it and counselled her to go to the ER to get proper care and to reach out to us about the outcome of the visit
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: PFIZER VACCINE WAS PLACED IN FREEZER 05062021 AND DUE TO BE MOVED TO REFRIGERATOR 05192021.  VACCINE WAS LEFT IN FREEZER UNTIL 05212021 THEN MOVED TO REFRIGERATOR.  IMMUNIZATION PROGRAM WAS NOTIFIED OF ISSUE ON 05252021 AND SENT EMAIL STATING  VACCINE AS SAFE TO USE .   05272021 TIP EMAILED  VACCINE WAS NOT SAFE TO USE AND TO DESTROY THE VACCINE.  THEN TIP EMAILED 05282021 THAT PFIZER PHARMACIST HAD DEEMED VACCINE STABLE AND IT WAS SAFE TO USE SO DOSES GIVEN 05252021 WERE GOOD.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Rash, Skin discolouration
Clinical narrative: I have a strange full arm rash/stripped skin discoloration on my right arm. It appeared two weeks after the shot and is still present. It does not itch and is not irritating. It looks like a series of stretch marks almost. It is slightly fading from an angry red to a lighter brown.   My body had a very bad reaction on the next day after the second shot. I anticipated that reaction, but not this skin discoloration / rash. I do not think it is going to go completely away. It is very strange.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: I just had flu like symptoms. I woke up in the middle of the night with stomach ache with a fever and chills with slight muscle aches. These symptoms would last for 20-22hrs.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood iron decreased, Blood thyroid stimulating hormone normal, Fatigue, Full blood count normal
Clinical narrative: Patient with persistent and chronic fatigue. She can no longer perform activities that she once did. She takes an hour nap in the morning and 2 hour nap in the afternoon. She has no energy. She no longer goes for walks.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Vitamin B12 normal, Vitamin D
Clinical narrative: Patient with persistent and chronic fatigue. She can no longer perform activities that she once did. She takes an hour nap in the morning and 2 hour nap in the afternoon. She has no energy. She no longer goes for walks.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Patient presented at facility for second dose of Pfizer. Patient received his first dose of Pfizer on 4/27/2021 at   location in another area. Patient developed a diffuse itchy rash over arms and legs one week after initial vaccine. Patient reports never had similar rash in the past. Continues to have severe itching and irritation now for past four weeks later. Dr recommended patient wait until rash has completely resolved. Patient can return for second Pfizer dose and will be monitored for one hour after.  Patient was referred to PCP for referral to allergist. Patient understood and is in agreement.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hypoaesthesia, Laboratory test normal, Magnetic resonance imaging, Neurological examination
Clinical narrative: The first day of the vaccine later that night I had body ache and chills (moderna ). The next day I leg  pain. after 4 weeks I still had leg pain with numbness and tingling started. I was told to take otc medication  for the leg pain and they gave me gabapentin the numbness and tingling. Ive been feeling like this since 04/25/2021 and today is June 07/2021. This vaccine is has done something to my body that the doctors cant find .
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Paraesthesia
Clinical narrative: The first day of the vaccine later that night I had body ache and chills (moderna ). The next day I leg  pain. after 4 weeks I still had leg pain with numbness and tingling started. I was told to take otc medication  for the leg pain and they gave me gabapentin the numbness and tingling. Ive been feeling like this since 04/25/2021 and today is June 07/2021. This vaccine is has done something to my body that the doctors cant find .
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Patient received first dose of Moderna Covid 19 Vaccine at approximately 10:20AM and shortly began complaining of trouble breathing. Assessed patient. Patient denied experiencing any lightheadedness or any itching. Gave patient 2 capsules of diphenhydramine 25mg (50mg total) at approximately 10:30AM. At 10:33AM patient breathing continued to become more labored. Administered 0.3mg of epinephrine into anterior right thigh. At 10:37AM,  EMT arrived on scene and continued to monitor and evaluate patient. Patient was transported to hospital.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Loss of consciousness, Pallor
Clinical narrative: patient was seated when received vaccine.  she was led to main waiting area to wait for observation.  about 5 to 10 min after the shot patient was seated and began to pass out.  she came to after a few min and put into lying down position with feet up.  appearance was  and clammy skin.  911 was called.  her blood pressure was normal.  heart rate normal.   911 call- based on my answers to their questions they decided to come to the pharmacy.   patient stated that she did not have much to eat and that she has passed out from a nose piercing in the past.  her color came back by the time she left.  ems checked her out.  she signed a form stating that she did not want taken to hospital.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Bleeding time prolonged
Clinical narrative: Significant very difficult to control bleeding with a very minor procedure. 3 hours of pressure required to control his bleeding.  Pt has received a testosterone pellet insert every 4 months since 2014. This involves a very small incision in the upper lateral buttocks. He has never had any complications or bleeding from prior insertions. He occasionally takes a Motrin and had taken one the night before; however nothing that could explain this uncontrollable  bleeding other than the fact that he had a Moderna vaccine series completed 1-2 months prior.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: PFIZER VACCINE WAS PLACED IN FREEZER 05062021 AND DUE TO BE MOVED TO REFRIGERATOR 05192021. VACCINE WAS LEFT IN FREEZER UNTIL 05212021 THEN MOVED TO REFRIGERATOR. IMMUNIZATION PROGRAM WAS NOTIFIED OF ISSUE ON 05252021 AND SENT EMAIL STATING VACCINE AS SAFE TO USE . 05272021 EMAILED  VACCINE WAS NOT SAFE TO USE AND TO DESTROY THE VACCINE. THEN EMAILED 05282021 THAT PFIZER PHARMACIST HAD DEEMED VACCINE STABLE AND IT WAS SAFE TO USE SO DOSES GIVEN 05252021 WERE GOOD.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Flushing
Clinical narrative: Patient Reported feeling flush and having chest tightness
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: FEVER OVER 102 DEGREES FOR APPROXIMATELY 72 HOURS.  NAUSEA AND VOMITTING FOR OVER 72 HOURS.  UNABLE TO KEEP DOWN ANY LIQUIDS OR TYLENOL.  VOMITTING EVERY 15 MINUTES OVER A 5 HOUR PERIOD BETWEEN HOURS 48 AND 53.  FINALLY ABLE TO GET ACCESS TO ONDANSETRON TO ALLEVIATE VOMITTING AND KEEP FROM GOING TO URGENT CARE FOR DEHYDRATION.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Lymphadenopathy
Clinical narrative: Doctors appointment on May 18th to address right arm swollen lymph node identified on May 13th.  On May 19th I experience the lost of my sense of taste and after my doctor's visit,  Steroids and NAC were prescribed.   It is now June 7th and I have yet to regain my sense of taste.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema
Clinical narrative: THE NEXT DAY 5/18/21 AT 900 AM WHEN PT WOKE UP NOTED TO HAVE ANGIOEDEMA ON THE FACE, BOTH CHEEKS  ARE SWOLLEN. Pt took Zyrtec per advise of provider, for 2 days, edema resolved but came back. after 4 days, then she took Zyrtec again for another 2 days.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Localized redness and soreness at injection site
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Condition aggravated, Pruritus, Rash, Skin exfoliation
Clinical narrative: Severe hair loss, severe rashes.  Extreme scaling on scalp.  Unbearable itching.  Scalp flaking. Over 30% hair loss. Still losing.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itchiness occurred 20 mins post vaccination
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Pt. received 2nd dose of Moderna vaccine 2 weeks after receiving the first dose on 5/20/2021, the recommended time frame is 28 days between doses. The dose was given during a clinic provided by the Department of Emergency Services and was administered by the nurse. This nurse has tried to contact client with no success, messages have been left on his voicemail.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Vaccination site reaction
Clinical narrative: About 9 days after receiving the second dose I noticed a red spot around the deltoid area where I received my vaccination.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: patient passed out for about 10-15 secs 5-10min after administration of the vaccine
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Rash erythematous
Clinical narrative: Patient with an erythematous rash on right cheek and scalp minutes after administration of vaccines. No signs of anaphylaxis.  Follow up with mother the following day by phone - rash had resolved.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fall, Nausea
Clinical narrative: Patient felt nauseous after vaccine and her mother tried to take her to the restroom.  When she stood up she got lightheaded.  Her mother caught her. She did not hit anything.  The paramedics were called.  She remained reclined on the floor until they arrived.  She said she felt fine. They monitored her for a short while. She required no further treatment.  On follow-up several hours later she states she feels fine.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Dizziness
Clinical narrative: PT started to feel "dizzy and complain of body burning". PT slumped over with no LOC. Reaction tam notified. PT remained slumped over for 10 minutes, then said she was starting to feel better. Talking normal, drinking water with no complaints. Sitting up on phone. PT stayed extra 30 minutes per reaction team order. Vitals as follows: 1426 Lying BP 137/89 HR 84 RR 16 SPO2 98%  1501 Lying BP 142/83 HR 60 RR 18 SPO2 96% 1520 Sitting BP 130/68 HR 84 RR 18 SPO2 98
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Patient presented for his second dose and noted lingering arm pain and difficulty raising left arm to shoulder height.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Muscular weakness, Pain
Clinical narrative: Patient presented for his second dose and noted lingering arm pain and difficulty raising left arm to shoulder height.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: I had a reaction at injection site nine days later. Injection site was red, swollen and very firm to the touch. It was about the size of a quarter and was very hot and sore.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Loss of consciousness, Syncope
Clinical narrative: Syncope. Felt very light headed, then said he was 'dreaming' but lost consciousness for a few seconds. Gave water, and orange juice when pt said he hadn't eaten. We moved him to the floor, where he laid down for a few minutes. He continued to sip water and OJ, and within a few minutes regained color and strength. Gradually felt better and back to baseline in about 15-20 minutes
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Patient reported progressively worsening dizziness and lightheadedness few minutes after receiving the 2nd dose of covid vaccine. EMS was called to evaluate the patient. Patient started feeling better about 15 minutes after and was able to leave the facility on her own.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Myocarditis, Troponin increased
Clinical narrative: Chest pain, elevated troponin, suspected myocarditis
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus, Vertigo
Clinical narrative: Vertigo and tinnitus
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Biopsy kidney abnormal, Biopsy skin abnormal, Blood creatinine increased, Blood test
Clinical narrative: Diffuse palpable purpuric rash, followed by acute kidney injury with gross hematuria and proteinuria
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Cutaneous vasculitis, Glomerulonephritis, Haematuria, Henoch-Schonlein purpura, IgA nephropathy
Clinical narrative: Diffuse palpable purpuric rash, followed by acute kidney injury with gross hematuria and proteinuria
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Proteinuria, Purpura, Urine analysis abnormal
Clinical narrative: Diffuse palpable purpuric rash, followed by acute kidney injury with gross hematuria and proteinuria
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Swelling, Vaccine positive rechallenge
Clinical narrative: Developed significant left axillary swelling and soreness - lasted about 2.5 to 3weeks - 1st shot was worse than the 2nd
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatine phosphokinase increased, Blood creatinine normal, Blood culture negative, Blood gases abnormal, Blood lactic acid
Clinical narrative: He received  a second dose of Moderna covid vaccine on 5/27 and progressed to develop some lethargy and decreased oral intake over the following days. When he arrived in the ED on 5/31 his temperature was 30.0?C rectally and bradycardic (HR51), BP 115/81, mentally altered. No evidence of infection or worsening of existing chronic conditions.  he was admitted to ICU for hypothermia.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone normal, Body temperature decreased, Bradycardia, Eosinophil percentage increased, Hypophagia
Clinical narrative: He received  a second dose of Moderna covid vaccine on 5/27 and progressed to develop some lethargy and decreased oral intake over the following days. When he arrived in the ED on 5/31 his temperature was 30.0?C rectally and bradycardic (HR51), BP 115/81, mentally altered. No evidence of infection or worsening of existing chronic conditions.  he was admitted to ICU for hypothermia.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Hypothermia, Intensive care, Lethargy, Lymphocyte percentage increased, Mental status changes
Clinical narrative: He received  a second dose of Moderna covid vaccine on 5/27 and progressed to develop some lethargy and decreased oral intake over the following days. When he arrived in the ED on 5/31 his temperature was 30.0?C rectally and bradycardic (HR51), BP 115/81, mentally altered. No evidence of infection or worsening of existing chronic conditions.  he was admitted to ICU for hypothermia.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Neutrophil percentage decreased, SARS-CoV-2 test negative, White blood cell count decreased
Clinical narrative: He received  a second dose of Moderna covid vaccine on 5/27 and progressed to develop some lethargy and decreased oral intake over the following days. When he arrived in the ED on 5/31 his temperature was 30.0?C rectally and bradycardic (HR51), BP 115/81, mentally altered. No evidence of infection or worsening of existing chronic conditions.  he was admitted to ICU for hypothermia.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Influenza like illness, Pain, Pyrexia
Clinical narrative: I received second Moderna dose on 6/06/2021 at 1:00 pm. At 2:00 am I woke up with fever, chills and full body aches. I feel like I have the flu with no energy.